BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9704766)

  • 1. A randomized trial on the use of ultrasonography or office hysteroscopy for endometrial assessment in postmenopausal patients with breast cancer who were treated with tamoxifen.
    Timmerman D; Deprest J; Bourne T; Van den Berghe I; Collins WP; Vergote I
    Am J Obstet Gynecol; 1998 Jul; 179(1):62-70. PubMed ID: 9704766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of transvaginal ultrasonographic and diagnostic hysteroscopic findings in postmenopausal breast cancer patients treated with tamoxifen.
    Gao WL; Zhang LP; Feng LM
    Chin Med J (Engl); 2011 Aug; 124(15):2335-9. PubMed ID: 21933565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology.
    Gerber B; Krause A; Reimer T; Mylonas I; Makovitzky J; Kundt G; Janni W
    Clin Cancer Res; 2006 Feb; 12(4):1245-50. PubMed ID: 16489080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of sonohysterography in asymptomatic postmenopausal tamoxifen-treated patients.
    Tepper R; Beyth Y; Altaras MM; Zalel Y; Shapira J; Cordoba M; Cohen I
    Gynecol Oncol; 1997 Mar; 64(3):386-91. PubMed ID: 9062139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saline sonohysterography for monitoring asymptomatic postmenopausal breast cancer patients taking tamoxifen.
    Elhelw B; Ghorab MN; Farrag SH
    Int J Gynaecol Obstet; 1999 Nov; 67(2):81-6. PubMed ID: 10636051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial evaluation with transvaginal US and hysterosonography in asymptomatic postmenopausal women with breast cancer receiving tamoxifen.
    Fong K; Kung R; Lytwyn A; Trudeau M; Chapman W; Nugent P; Glanc P; Manchul L; Szabunio D; Myhr T
    Radiology; 2001 Sep; 220(3):765-73. PubMed ID: 11526280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of transvaginal ultrasound and saline infusion sonohysterography for the evaluation of asymptomatic postmenopausal breast cancer patients on tamoxifen.
    Schwartz LB; Snyder J; Horan C; Porges RF; Nachtigall LE; Goldstein SR
    Ultrasound Obstet Gynecol; 1998 Jan; 11(1):48-53. PubMed ID: 9511196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The endometrium in asymptomatic breast cancer patients on tamoxifen: value of transvaginal ultrasonography with saline infusion and Doppler flow.
    Develioğlu OH; Omak M; Bilgin T; Esmer A; Tüfekçi M
    Gynecol Oncol; 2004 May; 93(2):328-35. PubMed ID: 15099941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
    Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
    J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transvaginal sonographic and hysteroscopic findings in postmenopausal women receiving tamoxifen.
    Marconi D; Exacoustos C; Cangi B; Perroni A; Zupi E; Valli E; Romanini C
    J Am Assoc Gynecol Laparosc; 1997 May; 4(3):331-9. PubMed ID: 9154782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data.
    Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Cuzick J; Coibion M; Bianco AR
    BJOG; 2003 Dec; 110(12):1099-106. PubMed ID: 14664881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen.
    Mourits MJ; Van der Zee AG; Willemse PH; Ten Hoor KA; Hollema H; De Vries EG
    Gynecol Oncol; 1999 Apr; 73(1):21-6. PubMed ID: 10094875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hysteroscopic assessment of menopausal breast-cancer patients taking tamoxifen; there is a bias from the mode of endometrial sampling in estimating endometrial morbidity?
    Garuti G; Grossi F; Cellani F; Centinaio G; Colonnelli M; Luerti M
    Breast Cancer Res Treat; 2002 Apr; 72(3):245-53. PubMed ID: 12058966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy.
    McGonigle KF; Shaw SL; Vasilev SA; Odom-Maryon T; Roy S; Simpson JF
    Am J Obstet Gynecol; 1998 Jun; 178(6):1145-50. PubMed ID: 9662294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ultrasonography, hysteroscopy, and biopsy in the diagnosis of endometrial lesions in postmenopausal tamoxifen-treated patients.
    Giorda G; Crivellari D; Veronesi A; Perin T; Campagnutta E; Carbone A; Scarabelli C
    Acta Obstet Gynecol Scand; 2002 Oct; 81(10):975-80. PubMed ID: 12366490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound, color flow Doppler, hysteroscopic and histological study.
    Exacoustos C; Zupi E; Cangi B; Chiaretti M; Arduini D; Romanini C
    Ultrasound Obstet Gynecol; 1995 Dec; 6(6):435-42. PubMed ID: 8903921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors of endometrial polyps resected from postmenopausal patients with breast carcinoma treated with tamoxifen.
    Cohen I; Azaria R; Bernheim J; Shapira J; Beyth Y
    Cancer; 2001 Sep; 92(5):1151-5. PubMed ID: 11571728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saline infusion sonography and office hysteroscopy to assess endometrial morbidity associated with tamoxifen intake.
    Garuti G; Cellani F; Grossi F; Colonnelli M; Centinaio G; Luerti M
    Gynecol Oncol; 2002 Sep; 86(3):323-9. PubMed ID: 12217755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of endometrial changes and p53 expression in tamoxifen treated women: comparison of various methods.
    Pokharel HP; Bhatla N; Kriplani A; Mukhopadhyay A; Srivastava A; Ralhan R
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):145-51. PubMed ID: 18603889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening.
    Love CD; Muir BB; Scrimgeour JB; Leonard RC; Dillon P; Dixon JM
    J Clin Oncol; 1999 Jul; 17(7):2050-4. PubMed ID: 10561257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.